Company / Operating Cash Flow
Pulmonx Corp Operating Cash Flow History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$31.5M
FY2025
5-year range
-$45.1M / -$30.6M
FY2021-FY2025
Trend
+16.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$45M to -$32M over the past 2 years.
Based on SEC 10-K filings.
-$32M in FY2025.
Improved from -$45M to -$32M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 16.1% year-over-year.
- Peak operating cash flow was recorded in FY2020.
- Lowest operating cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$31.5M | +16.1% |
| FY2024 | -$37.6M | +16.6% |
| FY2023 | -$45.1M | -8.9% |
| FY2022 | -$41.4M | -35.1% |
| FY2021 | -$30.6M | -66.5% |
| FY2020 | -$18.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026